CollPlant Biotechnologies Ltd Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
CollPlant Biotechnologies Ltd (CLGN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $5.07 per share for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2025-03-26
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|
| 2024-12-31 | $5.07 20-F · filed 2025-03-26 | |
| 2023-12-31 | $4.52 20-F · filed 2024-04-04 | |
| 2023-06-30 | $4.43 6-K · filed 2023-08-24 | |
| 2022-12-31 | $4.42 20-F · filed 2023-03-29 |